ACE I/D gene polymorphisms and polycystic ovary syndrome manifestations
- PMID: 38932810
- PMCID: PMC11196500
- DOI: 10.1007/s40200-023-01335-w
ACE I/D gene polymorphisms and polycystic ovary syndrome manifestations
Abstract
Objective: Polycystic ovary syndrome (PCOS) is a common multifactorial endocrine disorder affecting women of reproductive age. ACE enzyme is involved in the physiopathology of the ovarian system, and there are inconsistencies between studies regarding the association between ACE gene variants and PCOS. The objective of this study is to evaluate the association between ACE I/D gene polymorphisms and PCOS, as well as its clinical manifestations, in Iranian women with PCOS.
Design: This study included 140 patients with PCOS and 153 controls without the disease. Samples were collected from Yas Hospital Complex in Tehran-Iran during 2018 to 2022. Genomic DNA was obtained from whole blood samples using salt extraction, and genotyping was carried out using polymerase chain reaction (PCR).
Results: Variants of DD, ID, and II were observed in 31.4, 44.3, and 24.3% of PCOS, and 38.6, 44.1, and 17.2% of control group, respectively. The frequency of ACE gene variants did not differ between PCOS patients and control group. A significant difference was observed between the frequency of elevated LH to FSH ratio > 2 and ACE gene polymorphisms in patients with PCOS (OR: 0.32 (0.12-0.88), P value 0.024) with lower frequency observed in D allele carriers.
Conclusion: This study indicate that although ACE I/D variants frequency in PCOS women is similar to non-PCOS women, it may be involved in the pathogenesis of the disease through mechanisms regulating steroidogenesis in the ovary and suggests that ACE might be related to exacerbated clinical manifestations of PCOS which requires further investigations.
Keywords: ACE Gene Polymorphisms; I/D polymorphism; LH to FSH ratio; Polycystic ovary syndrome.
© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestThe authors declare no conflict of interest.
Figures


Similar articles
-
Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls.BMC Med Genet. 2009 Jul 14;10:64. doi: 10.1186/1471-2350-10-64. BMC Med Genet. 2009. PMID: 19602270 Free PMC article.
-
Association of Angiotensin-Converting Enzyme gene polymorphism in Pakistani women with the atypical steroidogenesis in Polycystic ovarian syndrome: A case-control study.Saudi J Biol Sci. 2021 Jun;28(6):3483-3489. doi: 10.1016/j.sjbs.2021.03.014. Epub 2021 Mar 14. Saudi J Biol Sci. 2021. PMID: 34121888 Free PMC article.
-
[Clinical Study of the Impact of ACE I/D Gene Variation on the Clinical Parameters of Patients with Polycystic Ovary Syndrome].Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 Sep;52(5):877-882. doi: 10.12182/20210960207. Sichuan Da Xue Xue Bao Yi Xue Ban. 2021. PMID: 34622609 Free PMC article. Chinese.
-
Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.Reprod Health. 2021 Jul 26;18(1):156. doi: 10.1186/s12978-021-01203-x. Reprod Health. 2021. PMID: 34311759 Free PMC article. Review.
-
Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS).Front Endocrinol (Lausanne). 2019 Feb 12;10:23. doi: 10.3389/fendo.2019.00023. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30809190 Free PMC article. Review.
References
-
- Puurunen J, Piltonen T, Morin-Papunen L, Perheentupa A, Järvelä I, Ruokonen A, et al. Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. J Clin Endocrinol Metab. 2011;96(6):1827–34. - PubMed
-
- Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod (Oxford England) 2012;27(10):3067–73. - PubMed
-
- Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F et al. The prevalence of polycystic ovary syndrome, its phenotypes and cardio-metabolic features in a community sample of Iranian population: Tehran lipid and glucose study. 2022;13:825528. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous